메뉴 건너뛰기




Volumn 26, Issue 1, 2001, Pages 21-26

Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis

Author keywords

[No Author keywords available]

Indexed keywords

ZINC SULFATE;

EID: 0035093566     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2001.00752.x     Document Type: Article
Times cited : (84)

References (28)
  • 6
    • 0005667706 scopus 로고    scopus 로고
    • A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution. Iraqi Central Organization for Specification and Quality Control/Patent Section. Patent No 2459. Baghdad, Iraq. 1993
    • Sharquie, K.E.1
  • 8
    • 0028783979 scopus 로고
    • A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution
    • (1995) J Dermatol (Japan) , vol.22 , pp. 732-737
    • Sharquie, K.E.1
  • 9
    • 0030782329 scopus 로고    scopus 로고
    • A comparative controlled clinical trial of intralesionally administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis
    • (1997) Clin Exp Dermatol , vol.22 , pp. 169-173
    • Sharquie, K.A.1    Najim, R.A.2    Farjou, I.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.